학술논문
A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (rg7713) in high-functioning adults with autism spectrum disorder
Document Type
Article
Author
Source
In: Neuropsychopharmacology . (Neuropsychopharmacology, 1 August 2017, 42(9):1914-1923)
Subject
Language
English
ISSN
1740634X
0893133X
0893133X